Form 4: Cigna Group Executive Jamie G. Kates Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Jamie G. Kates, Chief Accounting Officer of Cigna Group, reports acquisition and disposal of company stock and stock options on February 28, 2025.

Summary

  • On February 28, 2025, Jamie G. Kates, Chief Accounting Officer of Cigna Group, reported transactions involving Cigna's common stock.
  • Kates acquired 405 shares of common stock from the settlement of strategic performance shares for the 2022-2024 performance period.
  • An additional 246 restricted shares were acquired, vesting in three equal annual installments starting March 1, 2026.
  • 51 shares were withheld to cover tax obligations upon vesting of restricted shares at a price of $305.86.
  • 130 shares were withheld to cover tax obligations upon settlement of strategic performance shares at a price of $305.86.
  • Kates also acquired 871 employee stock options with an exercise price of $305.855, vesting in three equal annual installments beginning March 1, 2026, and expiring on February 28, 2035.
  • Following these transactions, Kates directly owns 1,686 shares of common stock and 871 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine transactions related to executive compensation and does not contain any overtly positive or negative information.

Positives

  • The acquisition of performance shares indicates achievement of pre-established company performance goals.
  • The vesting schedule of the restricted shares and stock options incentivizes long-term commitment from the executive.

Future Outlook

The vesting schedules for restricted shares and stock options suggest a focus on long-term performance and retention of key executives.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

  • Executive compensation packages often include a mix of salary, bonus, stock options, and restricted stock to align management's interests with those of shareholders.
  • Vesting schedules for stock options and restricted stock are common, typically ranging from three to five years.
  • The specific terms of these arrangements vary widely depending on the company's size, industry, and performance.

Stakeholder Impact

  • The transactions provide transparency to shareholders regarding executive compensation and ownership.
  • The vesting schedules for equity awards can incentivize employees and align their interests with those of shareholders.

Key Dates

DateDescription
02/28/2025Date of the reported transactions (acquisition and disposal of securities).
03/01/2026First vesting date for the restricted shares and employee stock options.
02/28/2035Expiration date for the employee stock options.
03/04/2025Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.